In all, 74.45% (258/347) NSCLC sections were classified as STYK1 positive while 47.84% (166/347) corresponding adjacent noncancerous tissue sections were classified as STYK1 positive. This evidence concerns the gene STYK1 and non-small cell lung carcinoma.